| Trial ID: | L2582 |
| Source ID: | NCT01022112
|
| Associated Drug: |
Ta-7284-Low
|
| Title: |
An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01022112/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: TA-7284-Low|DRUG: TA-7284-Low-middle|DRUG: TA-7284-High-middle|DRUG: TA-7284-High|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in Hemoglobin A1c (A1C) From Baseline (NGSP Value), 12 weeks | Secondary: Fasting Blood Glucose, Body Weight, 12 weeks|Safety and Tolerability, 14 weeks
|
| Sponsor/Collaborators: |
Sponsor: Mitsubishi Tanabe Pharma Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
383
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-11
|
| Completion Date: |
2010-09
|
| Results First Posted: |
2014-06-05
|
| Last Update Posted: |
2014-06-05
|
| Locations: |
Research site, Chugoku, Japan|Research site, Kanto, Japan|Research site, Kinki, Japan|Research site, Kyushu, Japan|Research site, Shikoku, Japan|Research site, Tohoku, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01022112
|
